Marketing Based on numbers provided current PMX usage globally (over 20,000 patients annually at $20K USD/patient (as per Spectral Investor Presentation). This current annual revenue is equivalent to over $500 million Canadian. Now, today sales are being realized by Toray and its distributors, but of course we (Spectral Medical Shareholders) own the rights to the largest healthcare market in the world (USA). The current Market Cap of Spectral is approx. $160 Million CAD. This Canadian Under the Radar play has about run its course. A $5+ Billion dollar annual revenue opportunity (with addition of EAA & SAM Pump), and this company is valued at $160 Million (had to point it out twice). Hard to imagine Shareholders allowing the inactivity in bringing attention to this opportunity to continue for much longer, as it is a grossly under told story especially in the USA.